Please wait while we retrieve your external webpage

Precision Medicine Success Hinges On Diagnostics’ Clinical Utility

One thought on “Precision Medicine Success Hinges On Diagnostics’ Clinical Utility

  1. Decoupling treatment from diagnosis is a critical priority in prostate cancer. Low and very low risk patients are appropriate candidates for active surveillance. It is encouraging to see molecular tests emerge that may help identify patients who are at low risk from their disease.

Leave a Reply